We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Maravai LifeSciences Holdings Inc (MRVI) USD0.01 A

Sell:$28.00 Buy:$28.01 Change: $0.06 (0.21%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.06 (0.21%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.06 (0.21%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The Company's segments include Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. It also provides research products for labeling and detecting proteins in cells and tissue samples. Its products include CleanCap, messenger ribonucleic acid (mRNA) and oligonucleotide. The Biologics Safety Testing focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing spectrum. The Company provides ultra-pure nucleotides to customers in the diagnostics, pharma, genomics and research markets.

Contact details

10770 Wateridge Circle Suite 200
Suite 200
United States
+1 (858) 5460004

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$7.26 billion
Shares in issue:
255.21 million
Life Sciences Tools & Services
United States
US dollar

Key personnel

  • Carl Hull
    Chairman of the Board, Chief Executive Officer
  • Kevin Herde
    Chief Financial Officer
  • Kurt Oreshack
    General Counsel, Secretary
  • Christine Dolan
    Chief Operating Officer - Biologics Safety Testing
  • Brian Neel
    Chief Operating Officer - Nucleic Acid Production

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.